Promising results of 6 months treatment with insulin detemir in Type 1 diabetic patients

被引：0
|
作者：
Selam, JL
Skeie, S
Vague, P
Bayer, T
Haahr, H
机构：
[1] Hop Hotel Dieu, Paris, France
[2] Hjertelaget Res Fdn, Stavanger, Norway
[3] Timone Hosp, Marseille, France
[4] Novo Nordisk, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
51
引用
收藏
页码：A15 / A15
页数：1
相关论文
共 50 条
  • [41] Insulin detemir provides superior glycaemic control than insulin NPH or insulin glargine in type 1 diabetic subjects in a clinical setting
    Jendle, Johan H.
    Norberg, Bengt
    DIABETES, 2007, 56 : A548 - A548
  • [42] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Miyakoshi, Kana
    Ikawa, Takashi
    Nakae, Rie
    Ochi, Fumihiro
    Tokuda, Masaru
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    DIABETES THERAPY, 2013, 4 (02) : 461 - 472
  • [43] Inhaled insulin: clinical results in type 2 diabetic patients
    Selam, JL
    DIABETES & METABOLISM, 2001, 27 (05): : S28 - S32
  • [44] THE LONG TERM EFFICACY OF INSULIN TREATMENT IN TYPE 2 DIABETIC PATIENTS, 36-MONTHS OBSERVATION PERIOD
    Farcasiu, E.
    ATHEROSCLEROSIS, 2014, 235 (02) : E190 - E190
  • [45] Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK
    Thalange, Nandu
    Gundgaard, Jens
    Parekh, Witesh
    Tutkunkardas, Deniz
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [46] Spotlight on insulin detemir in type 1 and 2 diabetes mellitus
    Chapman, TM
    Perry, CM
    BIODRUGS, 2005, 19 (01) : 67 - 69
  • [47] INSULIN ACTION IS NORMALIZED IN NEWLY DIAGNOSED TYPE-I DIABETIC-PATIENTS AFTER 3 MONTHS OF INSULIN-TREATMENT
    NIJS, HGT
    RADDER, JK
    FROLICH, M
    KRANS, HMJ
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (05): : 473 - 478
  • [48] LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY
    Wiesner, T.
    Schaedlich, P. K.
    Dippel, F. W.
    Koltermann, K.
    Hagenmeyer, E. G.
    VALUE IN HEALTH, 2010, 13 (07) : A294 - A294
  • [49] Cerebral Blood Flow and Glucose Metabolism in Appetite-Related Brain Regions in Type 1 Diabetic Patients After Treatment With Insulin Detemir and NPH Insulin A randomized controlled crossover trial
    van Golen, Larissa W.
    IJzerman, Richard G.
    Huisman, Marc C.
    Hensbergen, Jolanda F.
    Hoogma, Roel P.
    Drent, Madeleine L.
    Lammertsma, Adriaan A.
    Diamant, Michaela
    DIABETES CARE, 2013, 36 (12) : 4050 - 4056
  • [50] Usefulness of insulin detemir in Japanese children with type 1 diabetes
    Jinno, Kazuhiko
    Urakami, Tatsuhiko
    Horikawa, Reiko
    Kawamura, Tomoyuki
    Kikuchi, Nobuyuki
    Kikuchi, Tohru
    Kizu, Rika
    Kosaka, Kitaro
    Mizuno, Haruo
    Mochizuki, Takahiro
    Nishii, Aki
    Ohki, Yukashi
    Soneda, Shun
    Sugihara, Shigetaka
    Tatematsu, Toshi
    Amemiya, Shin
    PEDIATRICS INTERNATIONAL, 2012, 54 (06) : 773 - 779
12345